Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Altman, J.D., Moss, P.A., Goulder, P.J., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I.,
McMichael, A.J., and Davis, M.M. (1996). Phenotypic analysis of antigen-specific T
lymphocytes. Science 274, 94-96.
Amigorena, S., and Savina, A. (2010). Intracellular mechanisms of antigen cross presentation
in dendritic cells. Curr Opin Immunol 22, 109-117.
Annacker, O., Coombes, J.L., Malmstrom, V., Uhlig, H.H., Bourne, T., Johansson-Lindbom,
B., Agace, W.W., Parker, C.M., and Powrie, F. (2005). Essential role for CD103 in the T cellmediated
regulation of experimental colitis. J Exp Med 202, 1051-1061.
Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., Larsen,
C.P., and Ahmed, R. (2009). mTOR regulates memory CD8 T-cell differentiation. Nature
460, 108-112.
Asano, K., Nabeyama, A., Miyake, Y., Qiu, C.H., Kurita, A., Tomura, M., Kanagawa, O.,
Fujii, S., and Tanaka, M. (2011). CD169-positive macrophages dominate antitumor immunity
by crosspresenting dead cell-associated antigens. Immunity 34, 85-95.
Badovinac, V.P., Haring, J.S., and Harty, J.T. (2007). Initial T cell receptor transgenic cell
precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.
Immunity 26, 827-841.
Balachandran, V.P., Cavnar, M.J., Zeng, S., Bamboat, Z.M., Ocuin, L.M., Obaid, H.,
Sorenson, E.C., Popow, R., Ariyan, C., Rossi, F., et al. (2011). Imatinib potentiates antitumor
T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med 17,
1094-1100.
Basu, S., Binder, R.J., Suto, R., Anderson, K.M., and Srivastava, P.K. (2000). Necrotic but
not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal
to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12, 1539-1546.
Bear, A.S., Cruz, C.R., and Foster, A.E. (2011). T cells as vehicles for cancer vaccination. J
Biomed Biotechnol 2011, 417403.
Bedoui, S., Whitney, P.G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R.S.,
Wojtasiak, M., Shortman, K., Carbone, F.R., et al. (2009). Cross-presentation of viral and self
antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10, 488-495.
Belz, G.T., Smith, C.M., Kleinert, L., Reading, P., Brooks, A., Shortman, K., Carbone, F.R.,
and Heath, W.R. (2004). Distinct migrating and nonmigrating dendritic cell populations are
involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc
Natl Acad Sci U S A 101, 8670-8675.
Bennett, S.R., Carbone, F.R., Karamalis, F., Flavell, R.A., Miller, J.F., and Heath, W.R.
(1998). Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-
480.
Bennett, S.R., Carbone, F.R., Karamalis, F., Miller, J.F., and Heath, W.R. (1997). Induction
of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell
help. J Exp Med 186, 65-70.
Berd, D. (2004). M-Vax: an autologous, hapten-modified vaccine for human cancer. Expert
Rev Vaccines 3, 521-527.
Berger, C., Flowers, M.E., Warren, E.H., and Riddell, S.R. (2006). Analysis of transgenespecific
immune responses that limit the in vivo persistence of adoptively transferred HSV-
TK-modified donor T cells after allogeneic hematopoietic cell transplantation. Blood 107,
2294-2302.
238